These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
258 related items for PubMed ID: 7590665
1. Impaired biliary excretion and whole body elimination of methylmercury in rats with congenital defect in biliary glutathione excretion. Ballatori N, Gatmaitan Z, Truong AT. Hepatology; 1995 Nov; 22(5):1469-73. PubMed ID: 7590665 [Abstract] [Full Text] [Related]
2. Alterations in glutathione homeostasis in mutant Eisai hyperbilirubinemic rats. Lu SC, Cai J, Kuhlenkamp J, Sun WM, Takikawa H, Takenaka O, Horie T, Yi J, Kaplowitz N. Hepatology; 1996 Jul; 24(1):253-8. PubMed ID: 8707271 [Abstract] [Full Text] [Related]
3. Carrier-mediated mechanism for the biliary excretion of the quinolone antibiotic grepafloxacin and its glucuronide in rats. Sasabe H, Tsuji A, Sugiyama Y. J Pharmacol Exp Ther; 1998 Mar; 284(3):1033-9. PubMed ID: 9495864 [Abstract] [Full Text] [Related]
4. Mechanism of the tissue distribution and biliary excretion of the cyclic peptide octreotide. Yamada T, Niinuma K, Lemaire M, Terasaki T, Sugiyama Y. J Pharmacol Exp Ther; 1996 Dec; 279(3):1357-64. PubMed ID: 8968360 [Abstract] [Full Text] [Related]
5. Mechanisms of hepatic methylmercury uptake. Ballatori N, Truong AT. J Toxicol Environ Health; 1995 Nov; 46(3):343-53. PubMed ID: 7473862 [Abstract] [Full Text] [Related]
6. Effect of inhibition of gamma-glutamyltranspeptidase on biliary and urinary excretion of glutathione-derived thiols and methylmercury. Gregus Z, Stein AF, Klaassen CD. J Pharmacol Exp Ther; 1987 Jul; 242(1):27-32. PubMed ID: 2886637 [Abstract] [Full Text] [Related]
7. Kinetic analysis of hepatobiliary transport of organic anions in Eisai hyperbilirubinemic mutant rats. Sathirakul K, Suzuki H, Yasuda K, Hanano M, Tagaya O, Horie T, Sugiyama Y. J Pharmacol Exp Ther; 1993 Jun; 265(3):1301-12. PubMed ID: 8510010 [Abstract] [Full Text] [Related]
8. Different biliary excretion systems for glucuronide and sulfate of a model compound; study using Eisai hyperbilirubinemic rats. Takenaka O, Horie T, Suzuki H, Sugiyama Y. J Pharmacol Exp Ther; 1995 Sep; 274(3):1362-9. PubMed ID: 7562509 [Abstract] [Full Text] [Related]
9. gamma-Glutamyltransferase-dependent biliary-hepatic recycling of methyl mercury in the guinea pig. Dutczak WJ, Ballatori N. J Pharmacol Exp Ther; 1992 Aug; 262(2):619-23. PubMed ID: 1354255 [Abstract] [Full Text] [Related]
10. Biliary excretion of bile acid conjugates in a hyperbilirubinemic mutant Sprague-Dawley rat. Takikawa H, Sano N, Narita T, Uchida Y, Yamanaka M, Horie T, Mikami T, Tagaya O. Hepatology; 1991 Aug; 14(2):352-60. PubMed ID: 1860692 [Abstract] [Full Text] [Related]
11. Both cMOAT/MRP2 and another unknown transporter(s) are responsible for the biliary excretion of glucuronide conjugate of the nonpeptide angiotensin II antagonist, telmisaltan. Nishino A, Kato Y, Igarashi T, Sugiyama Y. Drug Metab Dispos; 2000 Oct; 28(10):1146-8. PubMed ID: 10997931 [Abstract] [Full Text] [Related]
12. Temocaprilat, a novel angiotensin-converting enzyme inhibitor, is excreted in bile via an ATP-dependent active transporter (cMOAT) that is deficient in Eisai hyperbilirubinemic mutant rats (EHBR). Ishizuka H, Konno K, Naganuma H, Sasahara K, Kawahara Y, Niinuma K, Suzuki H, Sugiyama Y. J Pharmacol Exp Ther; 1997 Mar; 280(3):1304-11. PubMed ID: 9067317 [Abstract] [Full Text] [Related]
13. Multispecific organic anion transporter is responsible for the biliary excretion of the camptothecin derivative irinotecan and its metabolites in rats. Chu XY, Kato Y, Niinuma K, Sudo KI, Hakusui H, Sugiyama Y. J Pharmacol Exp Ther; 1997 Apr; 281(1):304-14. PubMed ID: 9103511 [Abstract] [Full Text] [Related]
14. Increase in bile flow and biliary excretion of glutathione-derived sulfhydryls in rats by drug-metabolizing enzyme inducers is mediated by multidrug resistance protein 2. Johnson DR, Habeebu SS, Klaassen CD. Toxicol Sci; 2002 Mar; 66(1):16-26. PubMed ID: 11861969 [Abstract] [Full Text] [Related]
15. Mechanisms of biliary excretion of lithocholate-3-sulfate in Eisai hyperbilirubinemic rats (EHBR). Takikawa H, Nishikawa K, Sano N, Yamanaka M, Horie T. Dig Dis Sci; 1995 Aug; 40(8):1792-7. PubMed ID: 7648982 [Abstract] [Full Text] [Related]
16. Comparison of urinary excretion of pravastatin and temocapril in bile duct-ligated rats and Eisai hyperbilirubinemic rats (EHBR). Takada Y, Tachizawa H, Kurihara H, Takayanagi M, Sasamoto T, Akashi M, Aiso M, Takamori Y, Sano N, Takikawa H. J Hepatobiliary Pancreat Surg; 2004 Aug; 11(2):125-8. PubMed ID: 15127276 [Abstract] [Full Text] [Related]
17. Biliary excretion of estradiol-17 beta-glucuronide in the rat. Takikawa H, Yamazaki R, Sano N, Yamanaka M. Hepatology; 1996 Mar; 23(3):607-13. PubMed ID: 8617443 [Abstract] [Full Text] [Related]
18. Canalicular transport of reduced glutathione in normal and mutant Eisai hyperbilirubinemic rats. Fernández-Checa JC, Takikawa H, Horie T, Ookhtens M, Kaplowitz N. J Biol Chem; 1992 Jan 25; 267(3):1667-73. PubMed ID: 1730711 [Abstract] [Full Text] [Related]
19. Species differences in biliary excretion of methylmercury--role of non-protein sulfhydryls in bile. Urano T, Naganuma A, Imura N. Res Commun Chem Pathol Pharmacol; 1988 Nov 25; 62(2):339-51. PubMed ID: 3251340 [Abstract] [Full Text] [Related]
20. Canalicular multispecific organic anion transporter/multidrug resistance protein 2 mediates low-affinity transport of reduced glutathione. Paulusma CC, van Geer MA, Evers R, Heijn M, Ottenhoff R, Borst P, Oude Elferink RP. Biochem J; 1999 Mar 01; 338 ( Pt 2)(Pt 2):393-401. PubMed ID: 10024515 [Abstract] [Full Text] [Related] Page: [Next] [New Search]